How much to invest in glycemic control of a patient with diabetes mellitus type 2? A constant dilemma for the Brazilian Public Health System (SUS). (2019). Brazilian Journal of Pharmaceutical Sciences, 55, e17197. https://doi.org/10.1590/s2175-97902019000117197